A researcher in a lab looking at a tablet.

ALK+ Blog/News

  • ,

    Lung Cancer Awareness Month: lung cancer by the numbers

    “Because in our pain we must find each other – mirror to mirror the grace of our shared humanity, the stunningly broken beauty of our shared grief.And you can let

    Read More

  • ,

    ALK Positive funds two new clinical trials

    November is Lung Cancer Awareness Month, which is a good time to reflect on our successes as an organization. In 2020, we were excited to announce that the ALK Positive/LUNGevity

    Read More

  • The two most surprising risk factors for lung cancer

    Worldwide about 2,100,000 people are diagnosed with lung cancer every year. Approximately 85% of them have used tobacco products. Most are older and in poor health. It’s an insidious disease

    Read More

  • The use of traditional chemotherapy in lung cancer

    Many of us are on a tyrosine kinase inhibitor (TKI), however there are definite benefits to the use of traditional chemotherapy (chemo). In this article, we will learn a little

    Read More

  • Lung Cancer Research Awards funded by ALK Positive Inc. in partnership with LUNGevity Foundation

    ALK-positive lung cancer patients continue to fund research relevant to their survival FOR IMMEDIATE RELEASE WASHINGTON, DC (Date, 2020) — Patient group ALK Positive and LUNGevity Foundation today announced the

    Read More

  • ALK patients with hight PD-L1 expression and immunotherapy

    Many of our members are wondering if immunotherapy with current checkpoint inhibitors may be a good idea for them if they have been diagnosed with a high PD-L1 expression. Spoiler

    Read More

  • ,

    Side effects compliation & comparison

    IMPORTANT: This table is a list of various side effects members have shared.  Please remember, this is NOT a medical document.  Please use it as a guide and a starting point. 

    Read More

  • ,

    ALK-positive clinical trials & interview with multi-clinical ALK trial participant, Hazel Senz

    Member Hazel Senz from Golden, CO shares her experiences from participating in multiple ALK clinical trials and how they have affected the course of her disease. Hazel Senz has been

    Read More

  • What is Leptomeningeal Disease and how is it treated?

    A number of our members deal with leptomeningeal disease (LMD) at some point in their diagnosis. Read more on what LMD is and how it is treated. What is Leptomeningeal

    Read More

  • ALK-positive lung cancer and Covid-19 Update

    Written 7.1.20 We’ve been living with COVID-19 for six months now and we know so much more, not only about this virus, but how it affects people living with lung

    Read More

  • Brain Metastasis Radiation Options

    Radiation Options to Treat Brain Metastasis: Quick Review of WBR, SRS, and SFRT Nieder et. al. wrote an easy to understand paper on the management of patients with brain metastases

    Read More

  • ,

    Grapefruit & TKIs

    A Review: Interview with Dr. Lin, Does Grapefruit Interfere with TKIs? The interview with Dr. Lin covered topics that we should know about with regards to cytochrome P450 and its

    Read More